First tocilizumab products for Covid-19 prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Registration to the (Virtual) Joint UNICEF‒UNFPA‒WHO Meeting for Manufacturers and Suppliers taking place from 08 March to 10 March 2022 is now open.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
A Technical Consultation on WHO Prequalification Requirements for Mycobacterium tuberculosis complex (MTBC) NAT assays was held 22-24 November.
An online information session about the Prequalification of glucose monitoring devices was held for manufacturers on Friday 5 November.
The 9th annual collaborative registration procedure (CRP) meeting for National Regulatory Authorities (NRAs) was held 13 - 17 December.
The In Vitro Diagnostics Assessment Team continues its focus on assessing IVDs for detection of SARS-CoV-2 under the WHO Emergency Use Listing assessment procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Nirmatrelvir 150mg tablets + ritonavir 100mg tablets invited for COVID-19.
The WHO list of prequalified in vitro diagnostic products has been updated.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
See full report:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: